These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16846484)

  • 21. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. School-based screening for scoliosis: is it cost-effective?
    Thilagaratnam S
    Singapore Med J; 2007 Nov; 48(11):1012-7. PubMed ID: 17975691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
    Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
    J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of cervical cancer with screening programme in Branicevo District and cost-effectiveness analysis adjusted to the territory of the Republic of Serbia.
    Perovic S
    J BUON; 2009; 14(1):93-6. PubMed ID: 19373953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of serum markers for thrombophilia and autoimmune disease in reproductive age women with and without false positive rapid plasma reagin tests.
    Swica Y; Westhoff C
    Am J Reprod Immunol; 2009 Aug; 62(2):73-7. PubMed ID: 19614623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for cost reduction based on pre-admission MRSA screening in general surgery.
    Diller R; Sonntag AK; Mellmann A; Grevener K; Senninger N; Kipp F; Friedrich AW
    Int J Hyg Environ Health; 2008 Mar; 211(1-2):205-12. PubMed ID: 17692566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost effectiveness in context.
    Schechter CB
    J Clin Oncol; 2007 Feb; 25(6):609-10. PubMed ID: 17308263
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
    Flaherman VJ; Porco TC; Marseille E; Royce SE
    Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. False positive rates of thalassemia screening in rural clinical setting: 10-year experience in Thailand.
    Jopang Y; Thinkhamrop B; Puangpruk R; Netnee P
    Southeast Asian J Trop Med Public Health; 2009 May; 40(3):576-80. PubMed ID: 19842446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and costs of screening for aneurysms every 5 years after subarachnoid hemorrhage.
    Wermer MJ; Koffijberg H; van der Schaaf IC;
    Neurology; 2008 May; 70(22):2053-62. PubMed ID: 18420481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
    Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C
    Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.
    Oxlade O; Schwartzman K; Menzies D
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):16-26. PubMed ID: 17217125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fast track referrals for colorectal cancer: the impact of the faecal occult blood test screening programme.
    Ward N; Wright J; Marsh S; Norton J
    Colorectal Dis; 2007 Mar; 9(3):258-61. PubMed ID: 17298625
    [No Abstract]   [Full Text] [Related]  

  • 35. [Time for a discussion on general principles for screening].
    Werkö L
    Lakartidningen; 2003 May; 100(21):1908-11. PubMed ID: 12815877
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett's esophagus.
    Gerson L; Lin OS
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):319-25. PubMed ID: 17368231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
    Tarini BA; Christakis DA; Welch HG
    Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening.
    van Gils P; van den Berg M; van Kranen H; de Wit AG
    Eur J Cancer; 2009 Jun; 45(9):1554-9. PubMed ID: 19261464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cost effectiveness of screening for prostate cancer].
    Kaprin AD; Naĭgovzina NB; Ivanov SA; Bashmakov VA
    Vopr Onkol; 2006; 52(6):680-5. PubMed ID: 17338249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombophilia testing--reducing the burden.
    Ahmed S; Quinn J; Thornton P
    Ir Med J; 2012; 105(7):250. PubMed ID: 23008892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.